Opportunity Information: Apply for RFA DP 25 126
Apply for RFA DP 25 126
- The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.135.
- This funding opportunity was created on 2024-12-12.
- Applicants must submit their applications by 2025-02-28. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
- Each selected applicant is eligible to receive up to $5,902,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Previous opportunity: Celebrating the Contribution of African Food to American Cuisine
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DP 25 126
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DP 25 126) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIOSH Underground Mine Evacuation Technologies and Human Factors Research Apply for RFA OH 25 183 Funding Number: RFA OH 25 183 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $3,000,000 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 052 Funding Number: PAR 25 052 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAS 25 190 Funding Number: PAS 25 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Apply for PAR 25 035 Funding Number: PAR 25 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 034 Funding Number: PAR 25 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 25 267 Funding Number: PAR 25 267 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) Apply for PAR 25 268 Funding Number: PAR 25 268 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed) Apply for PAR 24 290 Funding Number: PAR 24 290 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) Apply for PAR 25 287 Funding Number: PAR 25 287 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Apply for PAR 25 286 Funding Number: PAR 25 286 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Apply for PAR 25 274 Funding Number: PAR 25 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required) Apply for RFA RM 24 008 Funding Number: RFA RM 24 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 24 076 Funding Number: RFA AI 24 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) Apply for RFA HL 26 017 Funding Number: RFA HL 26 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) Apply for RFA HL 26 016 Funding Number: RFA HL 26 016 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) Apply for PAR 25 281 Funding Number: PAR 25 281 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) Apply for RFA HL 26 020 Funding Number: RFA HL 26 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 25 226 Funding Number: PAR 25 226 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) Apply for PAR 25 282 Funding Number: PAR 25 282 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) Apply for RFA HL 26 018 Funding Number: RFA HL 26 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DP 25 126", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.